Vimarsana
Biggest News Aggregation in the World

Page 10 - Iagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iagnostics Today - Breaking & Trending Today

Machine learning could personalize diuretic treatment for patients with acute decompensated heart failure - Vimarsana News

Machine learning could personalize diuretic treatment for patients with acute decompensated heart failure

A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The Texas Heart Institute and led by his research and residency mentor, University of Texas Southwestern Medical Center's Dr. Ambarish Pandey, utilized a machine learning-based approach to identify, understand, and predict diuretic responsiveness in patients with acute decompensated heart failure (ADHF).

Machine learning unlocks personalized approach to early ovarian cancer detection - Vimarsana News

Machine learning unlocks personalized approach to early ovarian cancer detection

For over three decades, a highly accurate early diagnostic test for ovarian cancer has eluded physicians.

Bio-Techne's Advanced Cell Diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics - Vimarsana News

Bio-Techne's Advanced Cell Diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.

Omega-3 testing demand and potential held back by education and policy - Vimarsana News

Omega-3 testing demand and potential held back by education and policy

While there are huge benefits to testing and personalising omega-3 doses, this industry is being held back by a lack of consumer understanding, poor knowledge and support from healthcare professionals and policy barriers, according to speakers at this year's GOED Exchange.

European scientists target high-risk childhood cancer with liquid biopsy - Vimarsana News

European scientists target high-risk childhood cancer with liquid biopsy

Neuroblastoma mainly affects toddlers and young children - in the EU region there are 1500 new cases per year.